Search by Drug Name or NDC

    NDC 62332-0412-91 DEFERASIROX 360 mg/1 Details

    DEFERASIROX 360 mg/1

    DEFERASIROX is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is DEFERASIROX.

    Product Information

    NDC 62332-0412
    Product ID 62332-412_6d1323aa-ee46-43aa-bcf0-d83a36788a1c
    Associated GPIs 93100025000340
    GCN Sequence Number 073797
    GCN Sequence Number Description deferasirox TABLET 360 MG ORAL
    HIC3 C8A
    HIC3 Description METALLIC POISON,AGENTS TO TREAT
    GCN 38246
    HICL Sequence Number 033337
    HICL Sequence Number Description DEFERASIROX
    Brand/Generic Generic
    Proprietary Name DEFERASIROX
    Proprietary Name Suffix n/a
    Non-Proprietary Name DEFERASIROX
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 360
    Active Ingredient Units mg/1
    Substance Name DEFERASIROX
    Labeler Name Alembic Pharmaceuticals Inc.
    Pharmaceutical Class Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211824
    Listing Certified Through 2024-12-31

    Package

    NDC 62332-0412-91 (62332041291)

    NDC Package Code 62332-412-91
    Billing NDC 62332041291
    Package 1000 TABLET, FILM COATED in 1 BOTTLE (62332-412-91)
    Marketing Start Date 2019-11-21
    NDC Exclude Flag N
    Pricing Information N/A